CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close
Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

The future is in sight

For 30 years, CERA has worked to change how we understand, detect and treat eye disease.

Today, that research is helping identify conditions earlier, develop more targeted treatments, and bring us closer to preventing vision loss altogether.

But progress like this doesn’t happen on its own.

Together, we can accelerate what comes next.

Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea is transforming the delivery of ophthalmic clinical trials, increasing community access to sight-saving therapies and delivering excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News
Research

New findings provide clues for severe AMD

12 May 2026

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related macular degeneration.
News

Innovative AI glaucoma screening research recognised at Premier’s Awards

07 May 2026

A CERA researcher has won a Premier’s Award for Health and Medical Research for her work investigating the impact of artificial intelligence screening tools to detect people at risk of irreversible vision loss from glaucoma.
Stories

Winning the glaucoma game

23 February 2026

Asher Kozma is glad he’s stuck with CERA and taken part in cell-saving glaucoma research.
Research

Saving our cells

23 February 2026

CERA’s new lead researcher Professor Pete Williams is developing treatments for glaucoma that go beyond lowering pressure.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.